EYPT logo

EyePoint Pharmaceuticals, Inc. (EYPT)

Profile

Full Name

EyePoint Pharmaceuticals, Inc.

Ticker

NASDAQ: EYPT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 27, 2005

Indexes

Not included

Website

https://eyepointpharma.com

Employees

165

Key Details

Price

$13.49(+1.24%)

Market cap

$930.18M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$43.27M(-5.97% YoY)

Annual EPS

-$2.32(-27.47% YoY)

PE ratio

-

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $13.49
    EYPT price is $13.49

    30-Day Relative Volume

    0.71
    EYPT 30-day relative volume is 0.71

    Price Performance

    Price Today change

    +1.24%
    EYPT price is up +1.24% today

    Price YTD change

    +81.14%
    EYPT price is up +81.14% since January 1st

    Price 1-year change

    +51.97%
    EYPT price is up +51.97% year-on-year

    Price 3-year change

    +53.88%
    EYPT price is up +53.88% over the past 3 years

    Price Range

    Price All-time high

    $485.60
    EYPT price is currently -97.22% below its historical high of $485.60

    Price 3-year low

    $2.19
    EYPT price is currently +516.21% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $930.18M
    EYPT market capitalization is $930.18 million

    Market cap 3-year change

    +211.29%
    EYPT market capitalization is up +211.29% over the past 3 years

    Market cap All-time high

    $1.46B
    EYPT market capitalization is currently -36.16% below its historical high of $1.46 billion

    Market cap sector rank

    71.34%
    EYPT market capitalization is higher than 71.34% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +28.79%
    EYPT shares outstanding is up +28.79% year-on-year

    Shares Outstanding 3-Year Change

    +102.3%
    EYPT shares outstanding is up +102.3% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.28
    EYPT beta is 1.28

    200-day SMA

    $8.13
    EYPT price is currently +66.03% above its 200-day simple moving average

    50-day SMA

    $11.00
    EYPT price is currently +22.68% above its 50-day simple moving average

    RSI

    63.63
    EYPT 14-day relative strength index is 63.63

    Volume

    0.71
    EYPT 30-day relative volume is 0.71

    ATR

    $0.78
    EYPT average true range is $0.78

    10-day Historical Volatility

    100.49%
    EYPT 10-day historical volatility is 100.49%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $43.27M
    EYPT annual revenue is $43.27 million

    Revenue Analysts estimate

    $36.08M
    EYPT annual revenue is currently +19.93% higher than the consensus analysts' forecast

    Revenue 1-year change

    -5.97%
    EYPT annual revenue is down -5.97% year-on-year

    Revenue Sector rank

    60.45%
    EYPT annual revenue is higher than 60.45% of companies in Healthcare sector

    EPS

    EPS

    -$2.32
    EYPT annual earnings per share is -$2.32

    EPS Analysts estimate

    -$3.03
    EYPT annual earnings per share is currently -23.36% lower than the consensus analysts' forecast

    EPS 1-year change

    -27.47%
    EYPT annual earnings per share is down -27.47% year-on-year

    EPS Sector rank

    35.24%
    EYPT annual earnings per share is higher than 35.24% of companies in Healthcare sector

    Profit

    Gross profit

    $39.56M
    EYPT annual gross profit is $39.56 million

    Gross margin

    91.42%
    EYPT annual gross profit margin is 91.42%

    Operating profit

    -$145.85M
    EYPT annual operating income is -$145.85 million

    Operating margin

    -337.06%
    EYPT annual operating profit margin is -337.06%

    Net income

    -$130.87M
    EYPT annual net profit is -$130.87 million

    Net margin

    -302.43%
    EYPT annual net profit margin is -302.43%

    Expenses

    Total expenses

    $189.13M
    EYPT annual total expenses is $189.13 million

    Operating expenses

    $185.41M
    EYPT annual total operating expenses is $185.41 million

    Cost of goods sold

    $3.71M
    EYPT annual cost of goods sold is $3.71 million

    Selling, general & administrative expenses

    $0.00
    EYPT annual SGA is $0.00

    Depreciation and amortization

    $1.54M
    EYPT annual depreciation & amortization is $1.54 million

    Interest expense

    $0.00
    EYPT annual interest expense is $0.00

    Income tax

    $90.00K
    EYPT annual income tax is $90.00 thousand

    EBIT & EBITDA

    EBIT

    -$130.77M
    EYPT annual earnings before interest & taxes is -$130.77 million

    EBITDA

    -$129.23M
    EYPT annual EBITDA is -$129.23 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $418.46M
    EYPT annual total assets is $418.46 million

    Non current assets

    $35.16M
    EYPT annual long term assets is $35.16 million

    Current assets

    $383.31M
    EYPT annual total current assets is $383.31 million

    Cash and cash equivalents

    $370.91M
    EYPT annual cash & cash equivalents is $370.91 million

    Accounts receivable

    $607.00K
    EYPT annual accounts receivable is $607.00 thousand

    Inventory

    $2.31M
    EYPT annual inventory is $2.31 million

    Liabilities

    Total liabilities

    $81.96M
    EYPT annual total liabilities is $81.96 million

    Long term liabilities

    $32.92M
    EYPT annual total long term liabilities is $32.92 million

    Current liabilities

    $49.05M
    EYPT annual total current liabilities is $49.05 million

    Accounts payable

    $11.72M
    EYPT annual accounts payable is $11.72 million

    Debt

    Total debt

    $23.11M
    EYPT annual total debt is $23.11 million

    Total debt 1-year change

    +322.47%
    EYPT annual total debt is up +322.47% year-on-year

    Long term debt

    $21.86M
    EYPT annual long term debt is $21.86 million

    Short term debt

    $1.25M
    EYPT annual short term debt is $1.25 million

    Equity & Capital

    Shareholders equity

    $336.50M
    EYPT annual stockholders equity is $336.50 million

    Book value

    $336.50M
    EYPT annual book value is $336.50 million

    Retained earnings

    -$873.02M
    EYPT annual retained earnings is -$873.02 million

    Working capital

    $334.26M
    EYPT annual working capital is $334.26 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$126.23M
    EYPT annual cash flow from operations is -$126.23 million

    Cash from operations 1-year change

    -6832.05%
    EYPT annual cash flow from operations is down -6832.05% year-on-year

    Cash from investing

    -$219.35M
    EYPT annual cash flow from investing activities is -$219.35 million

    Cash from investing 1-year change

    -6517.04%
    EYPT annual cash flow from investing activities is down -6517.04% year-on-year

    Cash from financing

    $164.02M
    EYPT annual cash flow from financing activities is $164.02 million

    Cash from financing 1-year change

    -12.32%
    EYPT annual cash flow from financing activities is down -12.32% year-on-year

    CAPEX

    CAPEX

    $4.05M
    EYPT annual capital expenditures is $4.05 million

    CAPEX 1-year change

    +16.34%
    EYPT annual capital expenditures is up +16.34% year-on-year

    Free Cash Flow

    Free cash flow

    -$130.28M
    EYPT annual free cash flow is -$130.28 million

    Free cash flow 1-year change

    -8001.87%
    EYPT annual free cash flow is down -8001.87% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    91.42%
    EYPT annual gross profit margin is 91.42%

    Operating margin

    -337.06%
    EYPT annual operating profit margin is -337.06%

    Net margin

    -302.43%
    EYPT annual net profit margin is -302.43%

    ROA & ROE

    ROA

    -33.83%
    EYPT annual return on assets is -33.83%

    ROE

    -43.42%
    EYPT annual return on equity is -43.42%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    EYPT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    EYPT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.78
    EYPT price to book ratio is 3.78

    PB ratio Sector rank

    71.1%
    EYPT price to book ratio is higher than 71.1% of companies in Healthcare sector

    PS Ratio

    PS ratio

    17.92
    EYPT price to sales ratio is 17.92

    PS ratio Sector rank

    79.53%
    EYPT price to sales ratio is higher than 79.53% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $696.26M
    EYPT enterprise value is $696.26 million

    Enterprise value Sector rank

    68.98%
    EYPT enterprise value is higher than 68.98% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.72
    EYPT EV/EBITDA is -3.72

    EV/EBITDA Sector rank

    26.95%
    EYPT EV/EBITDA is higher than 26.95% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.81
    EYPT annual current ratio is 7.81

    Quick ratio

    7.77
    EYPT annual quick ratio is 7.77

    Leverage

    Debt to equity

    0.07
    EYPT annual debt to equity ratio is 0.07

    Interest coverage ratio

    -
    EYPT annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    EYPT piotroski f-score is 3

    Altman Z-Score

    3.92
    EYPT altman z-score is 3.92

    Analyst ratings

    Recent major analysts updates

    Aug 7, 25 Chardan Capital
    Buy
    Aug 6, 25 HC Wainwright & Co.
    Buy
    Jun 17, 25 RBC Capital
    Outperform
    May 29, 25 HC Wainwright & Co.
    Buy
    May 16, 25 Mizuho
    Outperform
    May 8, 25 Chardan Capital
    Buy
    Mar 6, 25 HC Wainwright & Co.
    Buy
    Mar 6, 25 Chardan Capital
    Buy
    Feb 6, 25 Chardan Capital
    Buy
    Jan 7, 25 Citigroup
    Buy

    Institutional Ownership

    Screeners with EYPT included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    • What is the ticker symbol for EyePoint Pharmaceuticals, Inc.?
    • Does EyePoint Pharmaceuticals, Inc. pay dividends?
    • What sector is EyePoint Pharmaceuticals, Inc. in?
    • What industry is EyePoint Pharmaceuticals, Inc. in?
    • What country is EyePoint Pharmaceuticals, Inc. based in?
    • When did EyePoint Pharmaceuticals, Inc. go public?
    • Is EyePoint Pharmaceuticals, Inc. in the S&P 500?
    • Is EyePoint Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is EyePoint Pharmaceuticals, Inc. in the Dow Jones?
    • When was EyePoint Pharmaceuticals, Inc.'s last earnings report?
    • When does EyePoint Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for EyePoint Pharmaceuticals, Inc.?

    The ticker symbol for EyePoint Pharmaceuticals, Inc. is NASDAQ:EYPT

    Does EyePoint Pharmaceuticals, Inc. pay dividends?

    No, EyePoint Pharmaceuticals, Inc. does not pay dividends

    What sector is EyePoint Pharmaceuticals, Inc. in?

    EyePoint Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is EyePoint Pharmaceuticals, Inc. in?

    EyePoint Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is EyePoint Pharmaceuticals, Inc. based in?

    EyePoint Pharmaceuticals, Inc. is headquartered in United States

    When did EyePoint Pharmaceuticals, Inc. go public?

    EyePoint Pharmaceuticals, Inc.'s initial public offering (IPO) was on January 27, 2005

    Is EyePoint Pharmaceuticals, Inc. in the S&P 500?

    No, EyePoint Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is EyePoint Pharmaceuticals, Inc. in the NASDAQ 100?

    No, EyePoint Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is EyePoint Pharmaceuticals, Inc. in the Dow Jones?

    No, EyePoint Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was EyePoint Pharmaceuticals, Inc.'s last earnings report?

    EyePoint Pharmaceuticals, Inc.'s most recent earnings report was on August 6, 2025

    When does EyePoint Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for EyePoint Pharmaceuticals, Inc. is November 5, 2025
    On this page